CTLA4 and melanoma: TRIMs scores can relatively accurately predict the treatment effects with anti-PD-1 checkpoint inhibitor or CTLA-4 blockade in melanoma (Additional file 1: Fig. S8B, AUC = 0.84 and 0.82).